[
    [
        {
            "time": "",
            "original_text": "【增减持】药明康德(02359.HK)遭摩根大通减持21.61万股",
            "features": {
                "keywords": [
                    "药明康德",
                    "摩根大通",
                    "减持"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【增减持】药明康德(02359.HK)遭摩根大通减持21.61万股",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【晨会聚焦】银行股大行情的历史梳理：美好时光还会再现？",
            "features": {
                "keywords": [
                    "银行股",
                    "历史梳理",
                    "大行情"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【晨会聚焦】银行股大行情的历史梳理：美好时光还会再现？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-03-04",
            "original_text": "【医药】江琦、赵磊：科创板专题报告：丰富医药创新企业上市路径，创新引领未来-20190304",
            "features": {
                "keywords": [
                    "科创板",
                    "医药创新",
                    "上市路径",
                    "创新引领未来"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【医药】江琦、赵磊：科创板专题报告：丰富医药创新企业上市路径，创新引领未来-20190304",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "昭衍新药股价创新高 创新板带来创新型医药资产重估机会？",
            "features": {
                "keywords": [
                    "昭衍新药",
                    "股价创新高",
                    "创新板",
                    "医药资产重估"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "昭衍新药股价创新高 创新板带来创新型医药资产重估机会？",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]